| Date | Company | Event | Description | Result |
|---|---|---|---|---|
| Tetraphase Pharmaceuticals | Phase 3 | Eravacycline, Complicated urinary tract infections | Failure | |
| TRACON Pharmaceuticals | PHASE 2 | TRC105, hepatocelluar carcinoma | Success | |
| Trevena | Phase 2b | TRV-130, Painkiller | Success | |
| Verastem | Phase 2 | VS-6063, Pleural mesothelioma | Failure |